Spiber
Engineering Protein Materials for Scalable Industrial Adoption

Synthetic fibers and animal-derived textiles continue to place pressure on supply chains, land usage and resource consumption. Spiber entered this environment with a biotechnology platform centered on Brewed Protein™ materials, produced through microbial fermentation using plant-based inputs. The company focuses on translating protein science into commercially usable fibers, films and resins for industrial manufacturing.

Its development process combines genetic design, fermentation and material processing into one connected production framework. Instead of limiting its work to laboratory experimentation, it built a manufacturing path capable of producing materials at industrial scale. That approach positioned Spiber beyond the pilot-stage limitations that often slow biomaterial ventures.
Expanding Protein Engineering Into Commercial Materials

Brewed Protein™ fibers are designed to reproduce qualities commonly associated with silk, wool and cashmere while reducing environmental burden during production. Internal lifecycle assessments highlighted reductions in greenhouse gas emissions, land use and water consumption compared with conventional animal fibers. The material also demonstrated biodegradability under marine conditions within six months in testing.

Spiber structured its platform around repeatable manufacturing steps. Natural protein data is collected and analyzed, DNA sequences are designed for targeted material traits and microorganisms produce proteins through fermentation. Those proteins are then processed into fibers, films or resin-like forms suitable for industrial applications. Continuous feedback between these stages accelerates material refinement and product development.

Commercial usage has expanded steadily through partnerships across the textile ecosystem. More than 40 brands and over 80 textile and yarn manufacturers have worked with Brewed Protein™ materials. Applications range from knitwear and outerwear to tailored garments and accessories, allowing manufacturers to test the material across different production environments and product categories.

Building Industrial Pathways Beyond Prototype Development

Scale became a central focus once Spiber moved beyond experimental batches. Its Thailand production facility enabled larger manufacturing volumes, allowing the material to enter broader commercial channels. Partnerships with firms such as ADM strengthened fermentation and supply chain capacity while supporting expansion into international markets.

European collaborations further demonstrated how the platform could integrate into existing textile production systems. Italian mill Botto Giuseppe developed yarns containing up to 100 percent Brewed Protein™ fiber, making it one of the first European manufacturers to commercialize fully protein-based yarns for apparel applications. The yarns were adapted for weaving, knitting and premium garment production.

Material development also moved outside apparel. New prototypes introduced at The Biofab Fair 2025 included a protein-based finishing treatment for polyester fabrics and a surface material capable of functioning as coatings or leather-like sheets. Those projects demonstrated how Spiber applies its protein platform across interiors, consumer products and vehicle materials.

Extending Biotechnology into Long-Term Commercial Use

Spiber’s business model centers on integrating biotechnology into existing manufacturing networks instead of replacing them entirely. Partnerships with mills, apparel brands and industrial producers allow Brewed Protein™ materials to enter familiar production workflows while introducing alternative material inputs. That strategy shortened adoption barriers for manufacturers evaluating biotechnology-based materials.

Research activity has also expanded toward food and ingredient applications through precision fermentation. The company has developed proteins capable of functions such as emulsification, binding and texturizing while maintaining a vertically integrated development structure from research through tonne-scale production. That broader platform signals how its protein engineering capabilities extend beyond textiles into multiple industrial categories.

Consistent manufacturing progress, commercial partnerships and measurable material performance established Spiber as a notable force within Japan’s biotechnology sector. Recognition as one of the Top 10 Biotech Japanese Startups 2026 reflects its ability to convert advanced protein science into scalable industrial products with growing global adoption.